HOME >> BIOLOGY >> NEWS
Green payments are the future of agricultural support

Boston -- New England farmers have and will continue to benefit from the Conservation Security Program, reported Kathleen Merrigan, PhD, to the United States Senate Committee on Agriculture, Nutrition, and Forestry in January. The Conservation Security Program (CSP) is the first comprehensive green payment system that pays farmers for good land stewardship. CSP is up for congressional reauthorization and possible reconfiguration in the 2007 farm bill. Merrigan's testimony sheds light on why CSP should be funded and how it can be fine-tuned to better meet farmers' needs.

"Green payments are the future of agricultural support and the CSP has succeeded in rewarding New England farmers for stewardship of working lands." Merrigan, director of the Agriculture, Food and Environment program and assistant professor at the Friedman School of Nutrition Science and Policy at Tufts University, presented results to the Senate Committee from a study that looked at the impact of the CSP on New England farmers.

"However, inadequate funding limited the eligibility of farms in New England to participate," said Merrigan. "As a result, New England received just 0.4 percent of contracts nationwide a total of $234,068 in CSP payments or 0.15 percent of funds distributed by USDA in the fiscal year under study."

"New England farmersand likely farmers nationwidewould benefit from acting on eight opportunities to strengthen CSP, a program that should remain central in our national conservation strategy." The eight opportunities outlined by Merrigan in her testimony are:

  • rewarding and motivating farmers by funding the CSP as intended

  • removing caps to reduce the complexity and improve the transparency of the CSP

  • increasing participation in the program by expanding technical assistance

  • recognizing the limits of the soil conditioning index

  • supporting small farms by est
    '"/>


Contact: Siobhan Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University
6-Feb-2007


Page: 1 2

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. Greenlands ancient forests shed light on stability of ice sheet
3. Green Junta
4. Green Nanotechnology: Its Easier Than You Think
5. Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
6. Stevens Center for Science Writings honors Edward O. Wilson with Green Book Award
7. Green Chemical Reactor Engineering -- XI
8. Climate changes are linked between Greenland and the Antarctic
9. Green plants share bacterial toxin
10. Mary Frances Lyon to receive Rockefellers Pearl Meister Greengard Prize
11. Green sturgeon receives threatened status

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Green payments are the future agricultural support

(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce ... Lyon County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center ... come from and how agriculture impacts their daily lives. This unique exhibit also features ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: